Cargando…

Caloric and nutrient intake in children with attention deficit hyperactivity disorder treated with extended-release methylphenidate: analysis of a cross-sectional nutrition survey

OBJECTIVES: To study calorie and nutrients intake in a group of patients diagnosed with attention deficit hyperactivity disorder (ADHD) under treatment with extended-release methylphenidate (MPH-ER), and to analyse the need to design nutrition intervention strategies. DESIGN: Observational (case-con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Durá-Travé, Teodoro, Gallinas-Victoriano, Fidel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012651/ https://www.ncbi.nlm.nih.gov/pubmed/25057372 http://dx.doi.org/10.1177/2042533313517690

Ejemplares similares

Dietary Pattern among Schoolchildren with Normal Nutritional Status in Navarre, Spain
por: Durá-Travé, Teodoro, et al.
Publicado: (2014)

Seasonal variations in calcidiol and parathyroid hormone levels in healthy children and adolescents in Navarre, Spain: a cross-sectional study
por: Durá-Travé, Teodoro, et al.
Publicado: (2016)

Vitamin D and Parathyroid Hormone during Growth Hormone Treatment
por: Durá-Travé, Teodoro, et al.
Publicado: (2022)

Pregnancy, Breastfeeding, and Vitamin D
por: Durá-Travé, Teodoro, et al.
Publicado: (2023)

Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate
por: van der Schans, Jurjen, et al.
Publicado: (2015)

Hyper-androgenemia and obesity in early-pubertal girls
por: Durá-Travé, T., et al.
Publicado: (2022)

Vitamin D status and parathyroid hormone assessment in girls with central precocious puberty
por: Durá-Travé, T., et al.
Publicado: (2022)

Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder
por: Pliszka, Steven R., et al.
Publicado: (2017)

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder
por: Wigal, Sharon B., et al.
Publicado: (2017)

Neuroretinitis Caused by Bartonella henselae (Cat-Scratch Disease) in a 13-Year-Old Girl
por: Durá-Travé, Teodoro, et al.
Publicado: (2010)

Prevalence of malnutrition in hospitalised children: retrospective study in a Spanish tertiary-level hospital
por: Durá-Travé, Teodoro, et al.
Publicado: (2016)

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
por: Huss, Michael, et al.
Publicado: (2016)

Effect of Aptensio XR (Methylphenidate HCl Extended-Release) Capsules on Sleep in Children with Attention-Deficit/Hyperactivity Disorder
por: Owens, Judith, et al.
Publicado: (2016)

Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists
por: Caballero, Joshua, et al.
Publicado: (2017)

Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015)

Population pharmacokinetics of methylphenidate hydrochloride extended-release multiple-layer beads in pediatric subjects with attention deficit hyperactivity disorder
por: Teuscher, Nathan S, et al.
Publicado: (2015)

Assessment of vitamin D status and parathyroid hormone during a combined intervention for the treatment of childhood obesity
por: Durá-Travé, Teodoro, et al.
Publicado: (2019)

Prevalencia de hipovitaminosis D y factores asociados en la edad infantojuvenil
por: Durá-Travé, Teodoro, et al.
Publicado: (2018)

Effects of the application of a prolonged combined intervention on body composition in adolescents with obesity
por: Durá-Travé, Teodoro, et al.
Publicado: (2020)

Clinical data and basal gonadotropins in the diagnosis of central precocious puberty in girls
por: Durá-Travé, Teodoro, et al.
Publicado: (2021)

Model-Based Approach for Establishing the Predicted Clinical Response of a Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder
por: Gomeni, Roberto, et al.
Publicado: (2020)

The Effects of Methylphenidate on Decision Making in Attention-Deficit/Hyperactivity Disorder
por: DeVito, Elise E., et al.
Publicado: (2008)

The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
por: İsmi, Onur, et al.
Publicado: (2018)

The Association Between Attention-Deficit Hyperactivity Disorder, Injuries, and Methylphenidate
por: Shem-Tov, Sharon, et al.
Publicado: (2019)

New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
por: Pitzianti, Maria Bernarda, et al.
Publicado: (2020)

Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder
por: Shirafkan, Hoda, et al.
Publicado: (2020)

Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
por: Mandali, Alekhya, et al.
Publicado: (2021)

Pica in an Adolescent with Attention Deficit Hyperactivity Disorder responsive to Methylphenidate
por: Bourgou, Soumaya, et al.
Publicado: (2021)

Continuity in Methylphenidate Treatment of Adults With Attention-Deficit/Hyperactivity Disorder
por: Olfson, Mark, et al.
Publicado: (2007)

Hypovitaminosis D and Cardiometabolic Risk Factors in Adolescents with Severe Obesity
por: Durá-Travé, Teodoro, et al.
Publicado: (2020)

Clinical use of a modified release methylphenidate in the treatment of childhood attention deficit hyperactivity disorder
por: Takon, Inyang
Publicado: (2011)

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder
por: Safavi, Parvin, et al.
Publicado: (2016)

Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder
por: Newcorn, Jeffrey H., et al.
Publicado: (2017)

Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?
por: Bukstein, Oscar G, et al.
Publicado: (2009)

Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
por: Nair, Rajasree, et al.
Publicado: (2009)

The Safety and Efficacy of Methylphenidate and Dexmethylphenidate in Adults with Attention Deficit/Hyperactivity Disorder
por: Sopko, Michael A., et al.
Publicado: (2010)

Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS)
por: Findling, Robert L., et al.
Publicado: (2014)

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder
por: Pagerols, Mireia, et al.
Publicado: (2018)

Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
por: Jaeschke, Rafał R., et al.
Publicado: (2021)

Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder?
por: Pereira Ribeiro, Johanne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bt5cnt3hvlgj9l4ud32rsiu30j